Toggle light / dark theme

Our memories are rich in detail: we can vividly recall the color of our home, the layout of our kitchen, or the front of our favorite café. How the brain encodes this information has long puzzled neuroscientists.

In a new Dartmouth-led study, researchers identified a neural coding mechanism that allows the transfer of information back and forth between perceptual regions to memory areas of the . The results are published in Nature Neuroscience.

Prior to this work, the classic understanding of brain organization was that perceptual regions of the brain represent the world “as it is,” with the brain’s visual cortex representing the external world based on how light falls on the retina, “retinotopically.” In contrast, it was thought that the brain’s memory areas represent information in an abstract format, stripped of details about its physical nature. However, according to the co-authors, this explanation fails to take into account that as information is encoded or recalled, these regions may in fact, share a common code in the brain.

Animals exhibit a diverse behavioral repertoire when exploring new environments and can learn which actions or action sequences produce positive outcomes. Dopamine release upon encountering reward is critical for reinforcing reward-producing actions1 3. However, it has been challenging to understand how credit is assigned to the exact action that produced dopamine release during continuous behavior. We investigated this problem with a novel self-stimulation paradigm in which specific spontaneous movements triggered optogenetic stimulation of dopaminergic neurons. Dopamine self-stimulation rapidly and dynamically changes the structure of the entire behavioral repertoire. Initial stimulations reinforced not only the stimulation-producing target action, but also actions similar to target and actions that occurred a few seconds before stimulation. Repeated pairings led to gradual refinement of the behavioral repertoire to home in on the target. Reinforcement of action sequences revealed further temporal dependencies of refinement. Action pairs spontaneously separated by long time intervals promoted a stepwise credit assignment, with early refinement of actions most proximal to stimulation and subsequent refinement of more distal actions. Thus, a retrospective reinforcement mechanism promotes not only reinforcement, but gradual refinement of the entire behavioral repertoire to assign credit to specific actions and action sequences that lead to dopamine release.

F.C. is the Director of Open Ephys Production Site.

A nice talk. At 18 minutes dude says healthspan is way more important than lifespan. Never mind that large sign behind him that says lifespan. But, not to knock it too much, yes healthspan is important too.


Dr. Oliver Medvedik, Dr. Aubrey de Grey, Dr. Peter Fedichev, Dr. Hanadie Yousef, Reason, and Dr. Hans Keirstead debate whether or not aging is truly reversible at the Longevity+DeSci Summit NYC (EARD 2023). \
\
Summary\
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀\
Dr. Oliver Medvedik earned his Ph.D. at Harvard Medical School in the Biomedical and Biological Sciences program. Oliver is presently the Director of the Kanbar Center for Biomedical Engineering at The Cooper Union, where he carries out research on improving gene targeting in mammalian cells, enzymatic oligonucleotide synthesis, and other bioengineering projects with undergraduate and graduate students at the Albert Nerken School of Engineering. Dr. Medvedik is also the co-founder of the community biotechnology laboratory, Genspace, located in Brooklyn, where he continues to serve on its board of directors. In addition, Dr. Medvedik is also co-founder and vice-president of the non-profit organization LEAF (Life Extension Advocacy Foundation), where he serves on the board of directors.\
\
➡️: / oliver-medvedik-4067016 \
\
Dr. Aubrey de Grey is a pillar of the longevity community. Dr. de Grey works on the development of medical innovations that can postpone all forms of age-related ill-health. His main focus is on rejuvenation: that is, the active repair of the various types of molecular and cellular damage which eventually cause age-related disease and disability, as opposed to the mere retardation of the accumulation of such damage. He is currently the President and Chief Scientific Officer of the Longevity Escape Velocity (LEV) Foundation. \
\
➡️: https://www.levf.org\
\
Dr. Peter Fedichev is an entrepreneur and scientist who co-founded three biotech companies: Quantum Pharmaceuticals, a drug discovery company, and Gero, a longevity startup, and GlyNeura, a biotech-pharma company aiming to cure Neurodegenerative Diseases. His scientific background lies in the fields of condensed matter physics, biophysics, and bioinformatics. His dream is to beat aging and experience life in space.\
\
➡️: https://gero.ai\
\
Dr. Handie Yousef is a leading expert on the biology of aging and mechanisms underlying tissue degeneration with over two decades of experience in biomedical research. In 2018, she launched Juvena Therapeutics, a venture-backed biotechnology company mapping the therapeutic potential of secreted proteins to develop biologics that prevent, reverse, and cure chronic, metabolic, and age-related diseases.\
\
➡️: https://www.juvenatherapeutics.com\
\
Reason is co-founder and CEO of Repair Biotechnologies. He has been an active angel investor in the longevity industry since its earliest days, with investments including Oisin Biotechnologies and Leucadia Therapeutics. He is a long-standing and well-connected patient advocate for aging research, involved in numerous fundraising and outreach initiatives conducted by organizations such as the Methuselah Foundation and SENS Research Foundation since the early 2000s. He is also the founder and writer of Fight Aging!, a noted news and commentary website in the biotechnology community. \
\
➡️: https://www.repairbiotechnologies.com\
\
Dr. Hans Keirstead is an internationally known stem cell expert and has led therapy development for cancer, immune disorders, motor neuron diseases, spinal cord injury, and retinal diseases. He is the Chairman and CEO of AIVITA Biomedical. Dr. Keirstead’s work in spinal cord injury earned him the distinction of being one of the 100 top scientists of the year in Discover Magazine. He was featured on 60 Minutes in a full segment covering his treatment for spinal cord injury. Dr. Keirstead and his research have also appeared in Newsweek, Inc. Magazine, WIRED, Esquire, The NY Times, TIME Magazine, Men’s Vogue, Science, and The American Spectator, amongst other national publications.\
\
➡️: / hanskeirstead \
\
FOLLOW US\
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀\
https://www.lifespan.io \
/ lifespanio \
/ lifespan.io \
\
HOW CAN YOU SUPPORT US?\
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀\
Lifespan.io, a 501©(3) nonprofit organization. \
► Support us with monthly donations by becoming a Lifespan Hero: https://www.lifespan.io/support\
► Subscribe: \
► Learn more, and help us: https://www.lifespan.io\
\
#longevity #EARD2023 #desci #decentralized #nft #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #research

Researchers taking part in the Human Brain Project have identified a mathematical rule that governs the distribution of neurons in our brains.

The rule predicts how neurons are distributed in different parts of the brain, and could help scientists create precise models to understand how the brain works and develop new treatments for neurological diseases.

In the wonderful world of statistics, if you consider any continuous random variable, the logarithm of that variable will often follow what’s known as a lognormal distribution. Defined by the mean and standard deviation, it can be visualized as a bell-shaped curve, only with the curve being wider than what you’d find in a normal distribution.

In their public lecture at Perimeter on May 1, 2019, neuroscientist Anne M. Andrews and nanoscientist Paul S. Weiss outlined their scientific collaboration and explained the importance of communicating across disciplines to target significant problems. \
\
Perimeter Institute (charitable registration number 88,981 4323 RR0001) is the world’s largest independent research hub devoted to theoretical physics, created to foster breakthroughs in the fundamental understanding of our universe, from the smallest particles to the entire cosmos. The Perimeter Institute Public Lecture Series is made possible in part by the support of donors like you. Be part of the equation: https://perimeterinstitute.ca/inspiri…\
\
Subscribe for updates on future live webcasts, events, free posters, and more: https://insidetheperimeter.ca/newslet…\
\
facebook.com/pioutreach \
twitter.com/perimeter \
instagram.com/perimeterinstitute \
Donate: https://perimeterinstitute.ca/give-today

I’m thinking my autistic sister has this. Maybe my 80 year old mother too. Short but informative article.


Neuroinflammation—as measured by levels of activated microglia, the brain’s immune cells—was strongly linked with irritability, agitation, and nighttime disturbances in people with dementia, recent research found. The results, published in JAMA Network Open, were based on data from a cross-sectional study that involved 109 participants aged 38 to 87 years, about two-thirds of whom did not have cognitive impairment.

Higher levels of microglial activation, and particularly microglial activation–associated irritability, in participants with dementia were also tied to greater distress in their caregivers, family members, or close friends.